Frazier Life Sciences portfolio
18 tracked investments, 4 on the map, $1.3B raised across the mapped portfolio.
Krystal BiotechPost-IPO Equity
Aspen NeuroscienceSeries C
Alentis TherapeuticsSeries D- AAllakosPost-IPO Equity
18 tracked investments, 4 on the map, $1.3B raised across the mapped portfolio.